latest news

News / Pharma

With $36 Million, Visus Starts Phase II Trial of Presbyopia Drop Brimochol

Conni Bergmann Koury / April 7, 2021
News / Pharma

Aura Biosciences Takes Key Steps to Advance Lead Candidate

News / Pharma

Biomedical Informatics Helps Focus Director Dr. Michael Chiang’s Vision for NEI

News

Big Things Happening for Kala Pharmaceuticals

News / Pharma

New Technology and Teamwork Are Key for Combining Forces

Pharmaceuticals & Genetics

With $36 Million, Visus Starts Phase II Trial of Presbyopia Drop Brimochol

April 7, 2021

Aura Biosciences Takes Key Steps to Advance Lead Candidate

March 31, 2021

Biomedical Informatics Helps Focus Director Dr. Michael Chiang’s Vision for NEI

March 23, 2021

New Technology and Teamwork Are Key for Combining Forces

March 16, 2021

What’s a SPAC? A Route to Public Markets for Gemini Therapeutics

March 3, 2021

Ocular Gene Therapy Takes Next Step Beyond Inherited Retinal Disease

February 23, 2021

devices & diagnostics

Emerging Glaucoma Devices See Beyond IOP

Emerging Glaucoma Devices See Beyond IOP

May 27, 2020
Soft CL slows myopia in children

Soft CL slows myopia in children

January 22, 2020
Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

September 18, 2019
Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

August 28, 2019
How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

August 20, 2019

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Ophthalmic Innovation To Your Inbox.
!
!
!
SUBSCRIBE

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

Subscribe To OIS News

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
!
!
!
Subscribe

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

next ois event

about ois

The OIS programs are presented annually by Healthegy, Inc.

Learn more about our world-class conferences.

Listen To The Podcast

OIS PODCAST 274 [ Industry Panel] - Thumbnail

Paul Karpecki, OD, FAAO, Leads Panel of Industry Experts in Discussion on Dry Eye Landscape

March 31, 2021
OIS Podcast
OIS PODCAST 273 [ Dry Eye Clinical Perspective] - Thumbnail (1)

Dr. Ashley Brissette Leads Discussion with KOLs on the Complexities and Management of Dry Eye Disease

March 24, 2021
OIS Podcast
MicrosoftTeams-image (28)

Building Trust in Business with Tracy Valorie

March 16, 2021
OIS Podcast
OIS PODCAST - [ Bruce Ksander] - Thumbnail

The Reversal of Age-Related Ophthalmic Disorders with Bruce Ksander, PhD

March 10, 2021
OIS Podcast
OIS PODCAST 270 [ KOL Perspective] - Thumbnail

KOLs Speak Out on the Future of Gene Therapy

March 3, 2021
OIS Podcast
OIS PODCAST - [ Vince Anido ] - Thumbnail

Sky’s the Limit with the Venerable Dr. Vicente Anido, Jr.

February 24, 2021
OIS Podcast

Deals

OIS Index Q2

OIS Index Rallies Back from COVID-Driven Decline

July 9, 2020
With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

June 10, 2020
AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

May 20, 2020
Covid-19 Impact on Healthcare Company Valuations & Financings

Covid-19 Impact on Healthcare Company Valuations & Financings

April 22, 2020
OIS Index: No Immunity to Coronavirus Selloff

OIS Index: No Immunity to Coronavirus Selloff

April 8, 2020

watch videos from ois tv

OIS Index

OIS Index Rallies Back from COVID-Driven Decline

OIS Index Posts a Strong Finish to 2019

OIS Index Outperforms

OIS Index on Positive Upswing

OIS Index Deep in Bear Territory in Q3

OIS Index Posts Modest Gain for Q2; Ophthalmic Market Leader Alcon Joins Index

OIS Index Delivers Stellar First-Quarter 2019 Performance

@oistweets